Short Interest in Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Expands By 110.0%

Key Points

• Reckitt Benckiser Group PLC experienced a significant increase in short interest, rising by 110.0% from 150,300 shares at the end of June to 315,600 shares by mid-July.
• The company announced a dividend of $0.2106 per share, with an exceptionally high yield of 341.0%.
• Analysts maintain a generally positive outlook, with an average rating of "Buy", including recent upgrades from Royal Bank Of Canada and Sanford C. Bernstein.

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) was the target of a significant growth in short interest in July. As of July 15th, there was short interest totaling 315,600 shares, agrowthof110.0% from the June 30th total of 150,300 shares. Based on an average daily trading volume, of 517,800 shares, the days-to-cover ratio is presently 0.6 days. Based on an average daily trading volume, of 517,800 shares, the days-to-cover ratio is presently 0.6 days.

Reckitt Benckiser Group Stock Up 1.2%

OTCMKTS RBGLY traded up $0.18 during trading hours on Thursday, hitting $15.03. 155,345 shares of the company were exchanged, compared to its average volume of 297,041. Reckitt Benckiser Group has a 52 week low of $10.68 and a 52 week high of $15.25. The stock has a 50-day moving average price of $14.07 and a 200 day moving average price of $13.46. The company has a current ratio of 0.56, a quick ratio of 0.37 and a debt-to-equity ratio of 1.01.

Reckitt Benckiser Group Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Thursday, September 25th. Investors of record on Monday, August 11th will be paid a $0.2106 dividend. The ex-dividend date of this dividend is Friday, August 8th. This represents a yield of 341.0%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. Royal Bank Of Canada reaffirmed an "outperform" rating on shares of Reckitt Benckiser Group in a research report on Friday, July 25th. Sanford C. Bernstein upgraded Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research note on Thursday, June 5th. Two analysts have rated the stock with a hold rating, two have issued a buy rating and four have given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Buy".

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.